4-methylumbilliferon (4-MU) as a Potential Treatment Against Cerebral ischemia and Reperfusion Injury in Rats; An Experimental Study
Introduction: Ischemic stroke (IS) is one of the three main fatal disorders and is a major health challenge. 4-methylumbelliferone (4-MU) is one of the coumarin derivatives (7–hydroxy‐4–methylcoumarin) with antioxidant and anti-inflammatory impact. This study was conducted to elucidate the neuropro...
Saved in:
| Main Authors: | Hamzeh Mirshekari Jahangiri, Alireza Moradi, Donya Nazarinia, Nahid Aboutaleb |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shahid Beheshti University of Medical Sciences
2024-09-01
|
| Series: | Archives of Academic Emergency Medicine |
| Subjects: | |
| Online Access: | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/2456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zhili decoction ameliorates ulcerative colitis by modulating gut microbiota and related metabolite, and inhibiting the TLR4/NF-κB/NLRP3 pathway
by: Tianying Tan, et al.
Published: (2024-12-01) -
Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
by: Cai Weiran, et al.
Published: (2025-08-01) -
Branched-chain fatty acids from goat milk alleviate ulcerative colitis via the TLR4/NF-κB/NLRP3 pathway
by: Jiaxin Zhang, et al.
Published: (2024-11-01) -
Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway
by: Shi Y, et al.
Published: (2025-01-01) -
Therapeutic potential of calcitriol in cerebral ischemia/reperfusion injury: In vivo and in silico insights into TLR4 and FGFR2 pathways
by: Fahimeh Ramshini, et al.
Published: (2025-12-01)